Friday, April 19, 2019 7:16:17 PM
flipper44,
For what it's worth you both have valid points to consider but with what has been said at the ASM by management and the board of directors about upcoming updates it's time to spill some beans worth counting. There is no reasonable time line update that should exceed 3 months from here based on what has been said and that should be stated. Linda knows we can't do the math with nebulous words like "multiple month process" even though she says we should be able to and that is a legitimate complaint. The price is set to respond by 8 months from November based on the charts. Either NWBO starts a news chain leading up to solid results or NWBO leaves longs to be left hanging once again which you and Umibe are warning them against. By July the ongoing investigation will be 3.5 years old with initial investigation research from NWBO being more than 4 years old. Funding from the property sale was to be used in part to fund Direct trials so NWBO needs to get them started before the funding is gone. The spend down from their property sale is now being reflected in the price as multiple months have passed since the ASM with no significant news. The picture of Dr. Linda Liau and DCVax-L was a nice reminder but longs need more than that except for those still accumulating. Those accumulating will help form a support base line before news and that will happen just as the charts predict. Those who expect this to be approved will step in with conviction when and if a final shake out is given a chance to occur by continued silence. Those who have not been through this before and lack conviction will get shaken.
By the way, in case you did not see my update, the post I wrote and spelled your name wrong in happened because I did not proof read before sending and auto correct turned a fat finger on phone misspelling of "would" into wild. Not intentional I assure you and sorry for those errors. I typed out a message quick and hit send when I was called into other duties. Best wishes.
For what it's worth you both have valid points to consider but with what has been said at the ASM by management and the board of directors about upcoming updates it's time to spill some beans worth counting. There is no reasonable time line update that should exceed 3 months from here based on what has been said and that should be stated. Linda knows we can't do the math with nebulous words like "multiple month process" even though she says we should be able to and that is a legitimate complaint. The price is set to respond by 8 months from November based on the charts. Either NWBO starts a news chain leading up to solid results or NWBO leaves longs to be left hanging once again which you and Umibe are warning them against. By July the ongoing investigation will be 3.5 years old with initial investigation research from NWBO being more than 4 years old. Funding from the property sale was to be used in part to fund Direct trials so NWBO needs to get them started before the funding is gone. The spend down from their property sale is now being reflected in the price as multiple months have passed since the ASM with no significant news. The picture of Dr. Linda Liau and DCVax-L was a nice reminder but longs need more than that except for those still accumulating. Those accumulating will help form a support base line before news and that will happen just as the charts predict. Those who expect this to be approved will step in with conviction when and if a final shake out is given a chance to occur by continued silence. Those who have not been through this before and lack conviction will get shaken.
By the way, in case you did not see my update, the post I wrote and spelled your name wrong in happened because I did not proof read before sending and auto correct turned a fat finger on phone misspelling of "would" into wild. Not intentional I assure you and sorry for those errors. I typed out a message quick and hit send when I was called into other duties. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
